Vocera to Present at Baird 2016 Healthcare Conference

Tuesday, August 23, 2016 GLOBE NEWSWIRE

SAN JOSE Calif Aug 23 2016 GLOBE NEWSWIRE Vocera Communications Inc NYSEVCRA the leading healthcare communications company today announced that Vocera executives will present and meet with institutional investors at the Baird 2016 Healthcare Conference on Wednesday Sept 7 at 1050 am ET in New ..

Immunophotonics Inc Announces First Patient Dosed in a Randomized Controlled Breast Cancer Clinical Trial for inCVAX A Novel Investigational ImmunoOncology Therapy

Tuesday, August 23, 2016 GLOBE NEWSWIRE

ST LOUIS Aug 23 2016 GLOBE NEWSWIRE Immunophotonics today announces that it has dosed its first patient in a randomized controlled clinical trial to further evaluate the efficacy of its developing cancer vaccine inCVAX ..

Vaccinex Inc Receives Orphan Drug Designation from US FDA for its Lead Antibody Product Candidate VX15 as a Potential Treatment for Huntingtons Disease

Tuesday, August 23, 2016 GLOBE NEWSWIRE

ROCHESTER NY Aug 23 2016 GLOBE NEWSWIRE Vaccinex Inc a clinicalstage biotechnology company engaged in the discovery and development of therapeutic monoclonal antibodies to treat patients with cancer and neurodegenerative diseases today announced that its lead antibody product candidate VX15 wh..

Zomedica Pharmaceuticals Corp Announces Second Quarter 2016 Financial Results

Tuesday, August 23, 2016 GLOBE NEWSWIRE

ANN ARBOR Mich Aug 23 2016 GLOBE NEWSWIRE Zomedica Pharmaceuticals Corp TSXVZOM Zomedica or Company a veterinary pharmaceutical company today reported unaudited condensed consolidated interim financial results for the three and six months ended June 30 2016 Amounts unless specified otherwise a..

Raptor Pharmaceutical to Present Data on QUINSAIR and Other Inhaled Antibiotics at the ERS International Congress

Wednesday, August 24, 2016 GLOBE NEWSWIRE

NOVATO Calif Aug 24 2016 GLOBE NEWSWIRE Raptor Pharmaceutical Corp NasdaqRPTP a biopharmaceutical company developing and commercializing transformative treatments for rare diseases today announced it will be participating in the European Respiratory Society ERS International Congress 2016 and ..

AbCellera Completes Antibody Discovery Project With Kodiak Sciences to Identify Lead Therapeutic Candidates

Wednesday, August 24, 2016 GLOBE NEWSWIRE

VANCOUVER British Columbia Aug 24 2016 GLOBE NEWSWIRE AbCellera Biologics Inc a biotechnology company specializing in the rapid discovery of monoclonal antibodies from natural immune cells announced today the successful completion of its antibody discovery partnership with Kodiak Sciences Th..

Rocky Mountain High Brands Appoints Former Deloitte Audit Partner as Chief Financial Officer

Wednesday, August 24, 2016 GLOBE NEWSWIRE

DALLAS Aug 24 2016 GLOBE NEWSWIRE Rocky Mountain High Brands Inc OTC PINKRMHB announced today that the Board of Directors appointed Mr Jens Mielke to fill the position of Chief Financial Officer as of August 22 2016 Jens has over 26 years of experience in accounting and finance leadership po..

Trxade Group Inc Appoints Independent Director

Wednesday, August 24, 2016 GLOBE NEWSWIRE

TAMPA Fla Aug 24 2016 GLOBE NEWSWIRE Trxade Group Inc OTCQBTRXD a webbased market platform with 6200 registered independent pharmacy customers that enables its customers to quickly source and purchase pharmaceuticals accessories and services from a wide range of manufacturers and drug distribu..

Flywire Expands its International Healthcare Payments Business

Thursday, August 25, 2016 GLOBE NEWSWIRE

BOSTON Aug 25 2016 GLOBE NEWSWIRE Flywire a leading provider of crossborder payment solutions is reporting strong demand for its healthcare payment platform as US hospitals ramp up competition for patients from outside the country Patients Beyond Borders estimates that the worldwide market f..

PetLife Pharmaceuticals Hires InnoVision Therapeutics in Preparation of Vitalzul FDA Submission

Thursday, August 25, 2016 GLOBE NEWSWIRE

HANCOCK Md Aug 25 2016 GLOBE NEWSWIRE PetLife Pharmaceuticals Inc OTCQBPTLF the Company a developer of a new generation of high potency veterinary cancer medications and nutraceuticals for pets is pleased to announce the signing of a contract with InnoVision Therapeutics a major step towards t..

Chembio Awarded Up to 132 Million US Government Contractto Develop and Commercialize PointofCare Tests for Zika Virus

Thursday, August 25, 2016 GLOBE NEWSWIRE

MEDFORD NY Aug 25 2016 GLOBE NEWSWIRE Chembio Diagnostics Inc NasdaqCEMI a leader in pointofcare POC diagnostic tests for infectious diseases today announced that it has been awarded a contract for up to 132 million in total funding from the US Department of Health and Human Services HHS Offic..

Patients Approach Two Years of Complete HIV Viral Load Suppression in Phase 2b PRO 140 Monotherapy Extension Study

Tuesday, August 23, 2016 GLOBE NEWSWIRE

VANCOUVER Washington Aug 23 2016 GLOBE NEWSWIRE CytoDyn Inc OTCQBCYDY a biotechnology company focused on the development of new antibody therapies for combating human immunodeficiency virus HIV infection announces that the first of 11 HIV1 patients receiving PRO 140 as a monotherapy in a Phase 2..

TaiGen Biotechnology OutLicenses Taigexyn Nemonoxacin to Productos Cientficos for the Latin American Market

Thursday, August 25, 2016 PR Newswire

TAIPEI Taiwan Aug 25 2016 PRNewswire TaiGen Biotechnology Company Limited TaiGen today announced that they have signed an exclusive licensing agreement with Productos Cientficos SA de CV PC a leading Mexican pharmaceutical company to develop and commercialize Taigexyn nemonoxacin in Latin America..

Seqirus to highlight new data in seasonal influenza prevention at Options IX for the Control of Influenza conference

Wednesday, August 24, 2016 PR Newswire

MAIDENHEAD United Kingdom Aug 242016 PRNewswire Seqirus announced today that seven poster presentations reporting results of the companys research and development in seasonal influenza prevention and control have been accepted at the Options IX for the Control of Influenza conference Options IX i..

Mylan Invalidates Two of Tevas Copaxone 40 mgmL Patents Via US Patent and Trademark Offices Inter Partes Review Proceeding

Wednesday, August 24, 2016 PR Newswire

HERTFORDSHIRE England and PITTSBURGH Aug 24 2016 PRNewswire Mylan NV NASDAQ TASE MYL today announced that the US Patent and Trademark Office PTO has ruled in favor of Mylan in its inter partes review IPR proceeding and found all claims of two related Copaxone 40 mgmL patents to be unpatentable The..

Amgen Provides Update On Status Of Parsabiv Etelcalcetide New Drug Application NDA Submitted To The US Food And Drug Administration FDA

Wednesday, August 24, 2016 PR Newswire

THOUSAND OAKS Calif Aug 24 2016 PRNewswire Amgen Nasdaq AMGN today announced that the US Food and Drug Administration FDA has issued a Complete Response Letter for the New Drug Application NDA for Parsabiv etelcalcetide for the treatment of secondary hyperparathyroidism sHPT in adult patients with..

Consumer Watchdog Applauds Unanimous CA Assembly Vote To Mandate Use of State Prescription Database to Spur Safe Opioid Prescribing

Wednesday, August 24, 2016 PR Newswire

SACRAMENTO Calif Aug 24 2016 PRNewswireUSNewswire With a unanimous vote the California Assembly approved SB 482 today legislation that will begin reversing the opioid overdose epidemic by requiring doctors to check patients prescription histories before prescribing The bill now heads to the Senate..

BioLife Solutions CryoStor Integrated in Kolon Groups CellMediated Gene Therapy for Osteoarthritis

Wednesday, August 24, 2016 PR Newswire

BOTHELL Wash Aug 24 2016 PRNewswire BioLife Solutions Inc NASDAQ BLFS a leading developer manufacturer and marketer of proprietary clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related cloud hosted biologistics cold chain management app for smart shipp..

Telesta Therapeutics Announces Execution of a Binding Purchase Agreement from ProMetic Life Sciences Inc

Wednesday, August 24, 2016 PR Newswire

MONTREAL Aug 24 2016 PRNewswire Telesta Therapeutics Inc TSX TST PNK BNHLF today announced that it has executed a binding Agreement subject to shareholder approval to be acquired by ProMetic Life Sciences Inc for consideration of 014Telesta share payable in freely tradable shares of ProMetic Life ..

ProMetic announces agreement to acquire Telesta Therapeutics Inc in all share transaction

Wednesday, August 24, 2016 PR Newswire

LAVAL QC Aug 24 2016 PRNewswire ProMetic Life Sciences Inc TSX PLI OTCQX PFSCF ProMetic or the Corporation announced today that it has entered into a binding agreement the Agreement for the acquisition of Telesta Therapeutics Inc Telesta by way of a plan of arrangement under the Canada Business Co..

TOP